|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$23.66 |
$23.82 |
$23.31 |
$23.51 |
426.90K | 04/15/2024 |
$23.50 |
$23.63 |
$22.91 |
$23.15 |
724.40K | 04/16/2024 |
$23.02 |
$23.65 |
$22.76 |
$23.39 |
714.30K | 04/17/2024 |
$23.52 |
$23.54 |
$22.76 |
$23.00 |
957.80K | 04/18/2024 |
$22.87 |
$23.44 |
$22.57 |
$22.66 |
971.20K |
|
Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Co. has marketed Korlym (mifepristone) in the U.S. for the treatment of patients with Cushing's syndrome. Co.'s primary compounds have entered the clinic as potential treatments for serious disorders, including Cushing's syndrome, solid tumors (such as ovarian cancer, castration-resistant prostate cancer and adrenocortical cancer with cortisol excess), antipsychotic induced weight gain and non-alcoholic steatohepatitis. | |
|
Corcept Therapeutics (CORT) has the following price history information. Looking back at CORT historical stock prices for the last five trading days, on April 12, 2024, CORT opened at $23.66, traded as high as $23.82 and as low as $23.31, and closed at $23.51. Trading volume was a total of 426.90K shares. On April 15, 2024, CORT opened at $23.50, traded as high as $23.63 and as low as $22.91, and closed at $23.15. Trading volume was a total of 724.40K shares. On April 16, 2024, CORT opened at $23.02, traded as high as $23.65 and as low as $22.76, and closed at $23.39. Trading volume was a total of 714.30K shares. On April 17, 2024, CORT opened at $23.52, traded as high as $23.54 and as low as $22.76, and closed at $23.00. Trading volume was a total of 957.80K shares. On April 18, 2024, CORT opened at $22.87, traded as high as $23.44 and as low as $22.57, and closed at $22.66. Trading volume was a total of 971.20K shares.
CORT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Corcept Therapeutics shares, starting with a $10,000 purchase of CORT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$4.28 |
|
End price/share: |
$22.66 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
429.44% |
|
Average Annual Total Return: |
18.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$52,938.46 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $23.51 | 04/15/2024 | $23.15 | 04/16/2024 | $23.39 | 04/17/2024 | $23.00 | 04/18/2024 | $22.66 |
|
|